“I think it is important to create this type of shared value partnership, which will help eliminate as many barriers of entry as possible.”

Dr. Seth Berkley

CEO Gavi, the Vaccine Alliance


“It's very clear that no one can do it alone. You need to have partners”

Dr. Nathalie Strub Wourgaft

Medical Director
Drugs for Neglected Diseases initiative (DNDi)


“We are clearing the path to promote effective introduction and scale-up of the new health technologies that are emerging from GHIT’s pipeline.”

Mr. Tetsuo Kondo

UNDP Representation Office in Tokyo


NEWSJourney with us through GHIT’s Past and Future

  • 2017.07.13 NEWS New interview articles have been released
  • 2017.06.05 NEWS GHIT Fund 5th Anniversary Film Released
  • 2017.06.01 NEWS New content "GHIT FUTURE" has been added
  • 2017.06.01 NEWS New interview articles have been released
  • 2017.05.10 NEWS New interview articles have been released
  • 2017.04.10 NEW SITE OPEN NEW GHIT Fund 5th Anniversary Website Launched

GHIT FUND HISTORYOur first 5 years (2013-2017)

GHIT FUND FUTUREPlans for the next 5 years (2018-2022)

STAKEHOLDER INTERVIEWSPerspectives from 15 global health leaders on
GHIT's catalytic role and Japan's transformational
contributions to global health R&D

GHIT Fund 5th Anniversary Film


Dr. Naoko YamamotoAssistant Minister for Global Health
Minister's Secretariat
Ministry of Health, Labour and Welfare
Dr. Hannah KettlerSenior Program Officer, Life Science Partnerships
Global Health Program, Office of the President
Bill & Melinda Gates Foundation

Available in August 2017

Prof. Stephen CaddickDirector, Innovations Division,
Wellcome Trust


Dr. David ReddyCEO
Medicine for Malaria Venture (MMV)
Mr. George NakayamaRepresentative Director, Chairman and CEO
Daiichi Sankyo Company, Limited
Prof. Kiyoshi KitaProfessor Emeritus, The University of Tokyo
Professor and Dean, Nagasaki University School of Tropical Medicine and Global Health


Mr. Christophe WeberRepresentative Director, President and CEO
Takeda Pharmaceutical Company Limited
Mr. Yoshihiko HatanakaRepresentative Director, President and CEO
Astellas Pharma Inc.
Dr. Nathalie Strub WourgaftMedical Director
Drugs for Neglected Diseases initiative (DNDi)


Dr. Jayasree K. IyerExecutive Director
Access to Medicine Foundation
Mr. Tetsuo KondoDirector
UNDP Representation Office in Tokyo

Available in August 2017

Dr. Aya YajimaTechnical Officer
Malaria, other Vectorborne and Parasitic Diseases Unit
Division of Communicable Diseases
World Health Organization Western Pacific Regional Office


Dr. Mark DybulFormer Executive Director
The Global Fund to Fight AIDS,
Tuberculosis and Malaria
Dr. Seth BerkleyCEO
Gavi, the Vaccine Alliance

Available in August 2017

Hon. Prof. Keizo TakemiMember of the House of Councillors of Japan
Chairman, Special Committee on Global Health Strategy
of the Liberal Democratic Party's Policy

SPONSOR INTERVIEWSOur shared vision drives creative partnerships for global health innovation

All Nippon Airways
Yahoo! JAPAN
salesforce.com Co.,Ltd.
Mori Building Co., Ltd.

Available in August 2017

STAFF STORYDiverse paths lead to global health R&D

Coming Fall 2017